Australian Life Sciences Stock News

Ramelius Resources (ASX:RMS) has just delivered its most profitable quarter on record, posting a 62% all in sustaining cost margin. Meanwhile, its share price has tracked lower alongside broader gold sector volatility. See our latest analysis for Ramelius Resources. Despite record profitability, Ramelius Resources’ recent momentum has cooled, with a 90 day share price return of a 27.97% decline and a year to date return of a 19.62% decline, even as the 3 year total shareholder return sits at...

Sonic Healthcare, one of the world's largest pathology providers, has recently reported that while revenue has grown over the past three years, profits have fallen sharply and the stock is now trading below its historical price-to-sales multiple. This combination of stronger top-line performance alongside weaker profitability raises important questions about how investors should interpret the company’s current valuation and operational trajectory. We’ll now examine how Sonic Healthcare’s...

Why Liontown's latest quarter matters for investors Liontown (ASX:LTR) just reported its strongest quarter since production began, with first time positive net cash flow linked to spodumene sales and an underground shift at Kathleen Valley, plus fresh expansion spending commitments. See our latest analysis for Liontown. The recent quarterly update and expansion plans appear to be feeding into strong momentum, with a 30 day share price return of 55.75% and a year to date share price return of...

Why PLS Group’s new debt deal matters for shareholders PLS Group (ASX:PLS) has closed a US$600 million 6.875% Senior Notes issue due 2031, refinancing its revolving credit facility and reshaping its debt profile to better match long term lithium operations. The company used part of the proceeds to repay the A$375 million drawn on its revolving credit facility, reducing the facility size from A$1,000 million to A$500 million. The remaining funds are earmarked for general corporate...

4DMedical Limited recently announced a one-year contractual engagement, commencing 1 May 2026, to provide its proprietary quantitative lung imaging analytics to GlaxoSmithKline, in association with Flywheel Exchange, in support of pulmonary drug development and clinical research. This agreement with one of the world’s large pharmaceutical companies adds to 4DMedical’s existing biopharma relationships and underlines growing use of its lung imaging platform in clinical trials. We’ll now...

ANZ Group Holdings (ASX:ANZ) has put its latest half year earnings in focus, with cash profit from continuing operations coming in ahead of market expectations and management flagging a cost reduction target of around 5% for 2026. See our latest analysis for ANZ Group Holdings. The stronger than expected half year result and planned 5% cost reduction target sit against a softer near term backdrop, with the share price down around 3% over the past quarter. However, a 1 year total shareholder...

Those following along with Telix Pharmaceuticals Limited ( ASX:TLX ) will no doubt be intrigued by the recent purchase...

Why Boss Energy is back in focus after weather hit production Interest in Boss Energy (ASX:BOE) has picked up after the company reported a sharp fall in quarterly uranium production due to rain related disruptions, while keeping FY26 cost guidance and accelerating key expansion projects. See our latest analysis for Boss Energy. The weather hit production update landed against a weak backdrop for holders, with the share price logging a 26.9% decline over 90 days and a 60.2% fall in 1 year...

South32 (ASX:S32) has flagged about US$1.1b in additional capital expenditure for the Taylor project at its Hermosa asset, taking total projected spend to roughly US$3.3b. First production has been pushed back from mid 2027 to mid 2028, with full capacity now targeted for FY2031, one year later than previously indicated. The update includes a 52% uplift in Ore Reserves, an extended mine life to around 33 years, and extra decline infrastructure aimed at improving long term operating...

BHP Group (ASX:BHP) is back in focus after its latest operating results, which showed higher iron ore and energy coal volumes, softer copper output, and a new yuan-linked iron ore pricing benchmark with Chinese buyers. See our latest analysis for BHP Group. BHP Group shares have climbed to A$54.94, with a 20.06% year to date share price return and a 50.28% 1 year total shareholder return. This suggests momentum has been building as iron ore linked news and production updates keep the stock in...

Securitize’s new agreement with Computershare (ASX:CPU) puts blockchain directly into the equity issuance process, allowing U.S. listed companies to create issuer sponsored tokenized shares that keep existing shareholder rights and regulatory frameworks intact. See our latest analysis for Computershare. The Securitize agreement lands as Computershare’s 1 month share price return of 6.7% and 7 day share price return of 2.3% contrast with a 10.0% year to date share price decline. At the same...

Capricorn Metals recently reported its March quarter, highlighting strong cash flows from the Karlawinda Gold Project and declaring its first fully franked interim dividend, while confirming the Karlawinda expansion remains on schedule for commissioning in early FY27. This combination of record cash generation, improved cost efficiency and a shift toward regular shareholder distributions marks an important maturation point in Capricorn Metals’ business profile. We’ll now examine how...

Elsight Limited recently held its Q1 2026 earnings call on 29 April 2026, following news that shareholder activist Stephen Mayne had nominated himself for election as a non-executive director under Rule 14.3 of the company’s constitution, a move the board has urged investors to vote against at the 29 May 2026 AGM. This combination of an upcoming contested board vote and fresh quarterly results puts Elsight’s governance approach and execution under closer investor scrutiny. We’ll now examine...

Emerald Resources recently reported strong half-year sales and net income and appointed Josh Redmond as Chief Operating Officer, marking a significant shift in its operational leadership structure. This combination of solid financial performance and an expanded executive bench is sharpening investor focus on how Emerald Resources executes its next phase of growth. We will now examine how Emerald Resources’ strengthened leadership team, highlighted by Josh Redmond’s appointment as COO,...

Viva Energy Group Limited recently reported that its total group sales volumes for the first quarter of 2026 rose to 4,302 ML from 4,092 ML a year earlier. This increase in volumes highlights stronger operational activity across the group’s fuel network, offering fresh context for how its existing growth plans may progress. We’ll now explore how this higher first-quarter sales volume interacts with Viva Energy’s existing investment narrative and expected earnings uplift. Capitalize on the AI...

IperionX recently shifted its Virginia facility to 24/7 continuous titanium production, advancing a government-backed push to build a domestic titanium supply chain for U.S. defense and industrial uses. This operational step, combined with fresh insider share purchases and long-dated equity awards, highlights management’s strong alignment with the company’s long-term titanium and critical minerals ambitions. We’ll now explore how the move to continuous titanium production shapes IperionX’s...

Woolworths Group (ASX:WOW) has revised its earnings outlook following its Q3 trading update. Management cited material cost pressures, including inflation and fuel price impacts, as key factors influencing the new guidance. The company flagged increasing competitive and regulatory headwinds in Australia and New Zealand, particularly affecting its New Zealand operations. Woolworths also highlighted geopolitical risks as a source of ongoing uncertainty for future profitability. Woolworths...

Deterra Royalties recently reported a stable March quarter, with resilient Mining Area C royalty cash flows offsetting softer iron ore prices and confirming a strong balance sheet position. The ongoing development of the Thacker Pass lithium project, supported by significant U.S. loan funding, underscores Deterra’s potential to broaden its royalty income beyond iron ore. We’ll now explore how this progress at Thacker Pass may influence Deterra Royalties’ existing investment narrative and...

Appen recently reported a quarterly update showing around 9% revenue growth, driven by strong performance in its China segment, while its core Appen Global division continued to suffer from steep revenue declines and EBITDA losses. Despite the contrasting fortunes of China and Appen Global, management kept full-year guidance unchanged, which appears to have frustrated investors looking for clearer evidence of a sustained turnaround in group profitability. We’ll now examine how the guidance...

Catalyst Metals recently released its quarterly update, reporting gold production of 26,127 ounces and reaffirming full-year output guidance of 100,000 to 110,000 ounces, while lifting its FY 2026 all-in sustaining cost guidance to A$2,750 to A$2,950 per ounce from A$2,200 to A$2,650. This sharp increase in expected per-ounce costs, despite steady production guidance, highlights growing margin pressure as a central issue for shareholders assessing the business. We will now examine how the...

Electro Optic Systems Holdings (ASX:EOS) is back in focus after reporting a A$518 million contract backlog at the end of March and positive operating cash flow, alongside talks on a conditional US$80 million laser weapons deal. See our latest analysis for Electro Optic Systems Holdings. The contract backlog update comes after a volatile stretch where the share price has a 7.14% 90 day share price return and the 1 year total shareholder return is extremely high, suggesting investor enthusiasm...

REA Group (ASX:REA) is opening its flagship Hackdays event to external real estate customers for the first time, putting AI driven product ideas and customer co design in sharper focus for investors. See our latest analysis for REA Group. At a share price of A$170.33, REA Group has a 30 day share price return of 6.28%, a year to date share price return of 7.82%, and a 1 year total shareholder return of 30.38%, which may indicate fading momentum despite its AI focused Hackdays push. If this...

In late April 2026, Mesoblast Limited reported it had completed patient recruitment for its pivotal 300-patient Phase 3 trial of rexlemestrocel-L in chronic low back pain due to degenerative disc disease, a placebo-controlled study designed around a 12-month pain reduction endpoint and supported by the therapy’s RMAT designation. This milestone moves rexlemestrocel-L closer to potential FDA submission for a condition affecting over 7 million Americans and heavily tied to opioid use,...

DroneShield (ASX:DRO) is back in focus after a sector wide lift in defence names, as governments increase spending on counter drone capabilities and the company heads into its Q1 2026 results and earnings call. See our latest analysis for DroneShield. DroneShield’s recent pullback, with a 30 day share price return of 9.3% and a 7 day decline of 3%, sits against a stronger 90 day share price return of 8.7% and a very large 1 year total shareholder return of 173.5%. This suggests longer term...